Literature DB >> 30885798

Knowledge about HPV and vaccination among young adult men and women: Results of a national survey.

Natália Luiza Kops1, Glaucia Fragoso Hohenberger2, Marina Bessel2, Jaqueline Driemeyer Correia Horvath2, Carla Domingues3, Ana Goretti Kalume Maranhão3, Flavia Moreno Alves de Souza4, Adele Benzaken4, Gerson Fernando Pereira4, Eliana Marcia Wendland5.   

Abstract

BACKGROUND: In addition to screening by Pap smears, vaccination against human papillomavirus (HPV) can dramatically reduce cervical cancers caused by the virus. The acceptance of HPV vaccination is directly related to HPV knowledge. This research aimed to evaluate knowledge about HPV and vaccination among men and women aged 16-25 years who use the public health system in Brazil.
METHODS: This was a cross-sectional, multicenter study of sexually active young adults recruited from 119 primary care units between 2016 and 2017. All participants answered a face-to-face standardized questionnaire.
RESULTS: Of 8581 participants, the mean percentage of correct answers about HPV and vaccination was 51.79% (95% CI 50.90-52.67), but 75.91% (95% CI 74.13-77.69) had awareness of the HPV vaccination. Women answered a higher proportion of questions correctly than men did (p = 0.0003). Lower education level was the variable that most interfered with knowledge. The best information sources for knowledge were both health professionals and the media (1.33%, 95% CI 1.03-1.70).
CONCLUSIONS: The results emphasize the importance of educational programs about HPV and vaccination among young adults, especially in socially disadvantaged populations. These findings can help to increase the vaccination rate in the country and to stimulate public health policies.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Public health; Sexual health; Sexually transmitted disease; Vaccination

Mesh:

Substances:

Year:  2019        PMID: 30885798      PMCID: PMC6426699          DOI: 10.1016/j.pvr.2019.03.003

Source DB:  PubMed          Journal:  Papillomavirus Res        ISSN: 2405-8521


Introduction

The strategy for vaccination against human papillomavirus (HPV) for women in Brazil through the National Immunization Program started in 2014 [1]. The age groups for this vaccination varied over the years, and men were included in the coverage of public vaccination (in 2017) [1]. Nonetheless, a decrease in vaccination coverage throughout the years of vaccination coverage was observed [1]. Decreasing coverage rates are observed in many countries around the world to be a challenge for public health disease prevention. HPV vaccination coverage is still lower than desirable in many countries [2], despite the growing evidence about its benefits [3]. This situation may be associated, according to some studies, not only with the absence of health promotion and prevention strategies [[4], [5], [6], [7]] but also with the difficulty in sensitizing adolescents, the age group with the lowest coverage for all vaccines [8]. The lack of interaction between vaccination strategies and educational actions by health professionals may lead to massive ignorance and consequential lack of prevention [4], since the acceptance of HPV vaccination is directly related to HPV knowledge [5]. HPV is a sexually transmitted infection (STI) that requires control, according to the Global Health Sector Strategy on STI 2016-2021 of the World Health Organization, due to high association with cervical cancer, which is responsible for 264,000 deaths in the world each year [9]. In addition, there is increasing evidence that HPV plays a relevant role in the development of anal, vulvar, vaginal, penile, head and neck cancers in both sexes [10]. In the fight against cervical cancer, it is established that in addition to screening by cytological examination, vaccination against HPV can dramatically reduce cancers caused by the virus [11]. For this reason, it is crucial that young people, who are the targets for HPV vaccination, have knowledge and awareness about the virus and the importance of the vaccine. The present study aimed to evaluate knowledge about HPV and vaccination among men and women aged 16–25 years who use the public health system in Brazil. This study also aimed to identify current sources of HPV information.

Methods

It was used data from the POP-Brazil Study, a nationwide, multicenter cross-sectional study that includes sexually active young adults from capitals of all 26 states and the Federal District across the five geographical regions. Besides Manaus, that also included a rural primary care unit, all other recruitment centers were in urban or peri-urban areas [12]. These young adults were recruited from 119 public primary care units between September 2016 and December 2017. Participants were invited via patient lists, during visits to health units, and during visits by community health agents or nurses in the school-based health promotion program. In all, 99.08% of eligible participants agreed to participate in the study. The manuscript follows reports of cross-sectional studies according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement [13]. The study was approved by the local research and ethics committees (number 1,607,032) and by the committees of the 26 Brazilian capitals and the Federal District of Brasília. All participants provided written consent after they were informed about the content of the study.

HPV knowledge and vaccination

For data acquisition, primary care professionals were trained in person by the central study coordinator. All participants responded to a face-to-face standardized interview that included the following data [14]: It was collected information on age, sex, race/skin color, education level, socioeconomic class, relationship status, and number of visits to primary care units in the last year. The Brazilian Criteria of Economic Classification (ABEP) were used to analyze socioeconomic class based on ownership of assets. All possessions have a score, and each class is defined by the sum of these scores [15]. HPV and vaccination knowledge assessment was based on Saulle et al. [16]. We categorized these items as dichotomic measures (correct = 1 or not correct = 0). The sum of correct questions was divided by the total number of questions (14 for men and 16 for women), ranging from 0 to 100% (Supplement 1). This sex difference in the number of questions arose because men did not answer questions related to Pap smears. The number of correct questions was presented as a continuous variable, with higher scores indicating more hits. The scores were divided into quartiles, and the lowest quartile (fewer correct answers) was compared to the higher quartile (more correct answers). To evaluate information sources, we asked, “How have you learned about HPV vaccination?” This question included multiple-choice responses (school, health professional, friends, media, or have not learned about it). To evaluate the best information source for HPV knowledge, we excluded the participants who had not learned about HPV vaccination. We also asked if the participant was already vaccinated against HPV. A study sample size of 7935 individuals was calculated to detect differences of 5% in HPV prevalence between regions with a power of 80% and an alpha error of 5% for women, using an estimate of 30% [17] for the prevalence of HPV in Brazil. To maximize diversity across regions, we divided the sample size into equal numbers among regions. We also weighted the measures by the size of the population in each capital within the age range and by sex. Brazil is a multicultural country of 207 million inhabitants, and this study represents approximately 7 million young adults from all capitals of the country [18].

Statistical analysis

Descriptive analysis was used to characterize the study population and to detect differences between groups. Categorical variables were summarized using absolute frequencies and percentages, while continuous variables were analyzed using means and confidence intervals (CIs) or medians and interquartile ranges (IQRs). Chi-square test and Student's t-tests were used when indicated. The answer option “don't know” was considered to be a missing value. Poisson regression with a robust variance model was conducted to examine factors associated with knowledge about HPV infection and vaccination by sex and with knowledge and vaccination based on the source of information about HPV vaccination. For the multivariable analyses, a theoretical framework was structured with the variables associated with the outcome: personal characteristics as age and skin color (Model 1), demographic factors as socioeconomic class and education level (Model 2), and behavior factors as relationship status and number of visits to primary care in the last year (Model 3). Analyses were performed using SAS software (Statistical Analysis System, SAS Institute Inc., Cary, N.C.), version 9.4, and statistical significance was defined as p < 0.05.

Results

Of the 8581 participants included in the study, 6366 were women. The mean age was 21.40 (95% CI 21.30-21.51) years. The majority defined themselves as mixed race/brown (56.76%, 95% CI 54.82-58.70) from social class C (55.75%, 95% CI 53.84-57.67), with a secondary education level (55.07%, 95% CI 53.13-57.00). Approximately 60% of participants visited the primary care unit 2 or more times in the last year, and differences between sexes were observed [women: 3 (IQR 1-5) and men: 2 (IQR 1-3), p = < 0.001] (data not shown). Overall, the mean percentage of correct answers was 51.79% (95% CI 50.90-52.67). Only 25% of participants correctly answered more than 68.75% of the questions. When compared the extreme quartiles, women had a higher proportion of correct answers about HPV and vaccination than men did (p = 0.0003) (Table 1). Moreover, the frequency of visits to primary care in the last year also had a positive influence on knowledge (p = 0.0013), as well as being divorced/widowed (p < 0.0001), being older than 20 years (p = 0.0018), having a higher education level (p < 0.0001) and being part of socioeconomic class A-B (p < 0.0001).
Table 1

Characteristics of participants according to knowledge about human papillomavirus (HPV) and vaccination. POP-Brazil Study 2016–2017.

VariablesOverallLower quartile
Higher quartile
p-valuea
Weighted % (n)
Sex0.0003
 Female261651.91 (1506)48.09 (1110)
 Male123262.11 (793)37.89 (439)
Age0.0018
 ≤ 20 years old178262.64 (1665)37.36 (617)
 Over 20 years old206653.48 (1134)46.52 (932)
Race/skin color0.0666
 White93451.12 (534)48.89 (400)
 Black57662.71 (369)37.29 (207)
 Pardo222459.14 (1325)40.86 (899)
 Others8447.75 (46)52.25 (38)
Education level<.0001
 Primary (some or complete)88977.77 (691)22.23 (198)
 Secondary (some or complete)208057.55 (1274)42.45 (806)
 University level or higher87831.03 (333)68.97 (545)
Socioeconomic class<.0001
 A-B74645.34 (364)54.66 (382)
 C198054.19 (1147)45.81 (833)
 D-E112272.07 (788)27.93 (334)
Relationship status<.0001
 Single or without partner96950.77 (518)49.23 (451)
 Dating or flirting148653.92 (829)46.08 (657)
 Married or living together135466.89 (928)33.11 (426)
 Divorced or widowed3843.39 (23)56.61 (15)
Number of visits to primary care in the last year0.0013
 084360.97 (535)39.03 (308)
 178064.81 (495)35.19 (295)
 2 or 3111254.99 (649)45.01 (463)
 ≥ 4111152.72 (618)47.28 (493)

Chi-square test.

Characteristics of participants according to knowledge about human papillomavirus (HPV) and vaccination. POP-Brazil Study 2016–2017. Chi-square test. Regarding the characteristics associated with knowledge by sex, the multivariate model showed that among women, being black, being part of socioeconomic classes C and D/E, having a primary and secondary-level education, and did not visit the primary care unit were associated with low knowledge levels, whereas older age and to be dating or flirting were associated with high knowledge levels. Among men, primary and secondary education levels, divorced/widowed status, and number of visits to primary care were associated with having fewer correct answers (Table 2). When we excluded the vaccinated participants or included them in the adjustment, the results remained the same.
Table 2

Multivariate analysis of characteristics associated with HPV knowledge by sex. POP-Brazil Study, 2016–2017.

VariablePrevalence ratio (95% Confidence Interval)
Women
Men
Model 1Model 2Model 3Model 1Model 2Model 3
Age
 ≤ 20 years old111111
 Over 20 years old0.79 (0.71–0.88)0.89 (0.80–0.99)0.87 (0.78–0.97)0.91 (0.79–1.05)0.97 (0.85–1.10)0.94 (0.82–1.07)
Skin color/race
 White111111
 Black1.37 (1.15–1.64)1.23 (1.04–1.45)1.24 (1.05–1.45)1.12 (0.87–1.44)0.98 (0.79–1.23)0.98 (0.78–1.22)
 Pardo1.12 (0.96–1.31)1.00 (0.87–1.16)0.99 (0.86–1.14)1.17 (0.97–1.43)1.12 (0.94–1.34)1.11 (0.93–1.33)
 Others0.89 (0.56–1.40)0.85 (0.54–1.33)0.87 (0.56–1.37)0.93 (0.49–1.78)0.80 (0.47–1.37)0.84 (0.51–1.38)
Socioeconomic class
 A-B1111
 C1.30 (1.03–1.65)1.27 (1.00–1.60)0.89 (0.73–1.09)0.88 (073–1.08)
 D-E1.46 (1.15–1.86)1.41 (1.11–1.80)1.12 (0.92–1.36)1.06 (0.87–1.29)
Education level
 Primary (some or complete)2.44 (1.92–3.10)2.37 (1.85–3.03)2.28 (1.71–3.03)2.23 (1.69–2.96)
 Secondary (some or complete)1.88 (1.49–2.38)1.86 (1.47–2.35)1.71 (1.30–2.26)1.72 (1.31–2.25)
 University level or higher1111
Relationship status
 Single or without partner0.87 (0.75–1.02)0.84 (0.70–1.01)
 Dating or flirting0.84 (0.75–0.96)0.95 (0.82–1.09)
 Married or living together11
 Divorced or widowed0.61 (0.32–1.17)1.54 (1.24–1.91)
Number of visits to primary care in the last year
 01.23 (1.07–1.42)1.21 (0.99–1.48)
 11.08 (0.93–1.26)1.27 (1.04–1.55)
 2 or 31.05 (0.91–1.20)1.09 (0.88–1.36)
 ≥ 411
Multivariate analysis of characteristics associated with HPV knowledge by sex. POP-Brazil Study, 2016–2017. Approximately 46.30% (95% CI 44.14-48.46) of subjects believed that HPV has signs and symptoms; there were no significant differences between sexes (p = 0.164). Regarding HPV-related diseases, some differences between men and women's answers were noted (Fig. 1). Women were more aware of the association between HPV and cervical cancer, while men had more knowledge about the association between HPV and anal and esophageal cancer.
Fig. 1

Knowledge on HPV-associated cancers according to sex. The answer option “don't know” was considered to be a missing value.

Knowledge on HPV-associated cancers according to sex. The answer option “don't know” was considered to be a missing value.

Attitudes toward and awareness about HPV vaccination

Of the 8577 participants, 7.48% (95% CI 6.69-8.27) were vaccinated against HPV. The scores for HPV knowledge among vaccinated subjects were significantly higher than those among nonvaccinated subjects [59.52% (95% CI 58.36-60.69) versus 51.17% (95% CI 50.0-51.65), respectively]. When differences between sexes were analyzed, 54.71% (n = 5618) of nonvaccinated women had correct answers, compared to 60.27% (n = 745) of vaccinated women (p < 0.001). A total of 47.90% (n = 2139) of nonvaccinated men had correct answers, compared to 55.26% (n = 75) of vaccinated men (p = 0.022) (data not shown). The most common reasons for not receiving the vaccination were being outside of the age group covered by the public health system (41.01%, 95% CI 38.70-43.31), not knowing about the vaccine (22.53%, 95% CI 20.56-24.49), not having received medical advice about the vaccine (20.96%, 95% CI 19.17-22.74) and paying for the vaccine (6.11%, 95% CI 5.09-7.12). Only 2.79% (95% CI 1.97-3.61) were not vaccinated due to side effects. Among women, 97.70% (95% CI 97.07-98.32) reported that they would undergo a Pap smear even after receiving the vaccine.

Information source

Of the participants, 75.91% (95% CI 74.13-77.69) reported that they had already been aware of HPV vaccination. Most participants were informed by the media (television, Internet and/or radio) [35.05% (95% CI 33.27-36.82)], followed by health professionals [25.03% (95% CI 23.32-26.74)], school [12.57% (95% CI 11.35-13.79) or friends [6.22% (95% CI 5.35-7.09)] (data not shown). On the other hand, the information source associated with higher scores for HPV knowledge was the combination of both health professionals and the media. Participants informed by these two sources had a 33% increase in the number of correct answers in relation to those informed by other sources (1.33%, 95% CI 1.03-1.70). Being informed by friends was a risk factor for having less knowledge (0.69%, 95% CI 0.49-0.96). Those who were informed by two sources other than the media and health professionals did not show a significant difference in knowledge from participants informed by only one source (Fig. 2). The results remained similar when adjusted for the frequency of visits to primary care in the last year.
Fig. 2

HPV knowledge and vaccination by information source. POP-Brazil Study, 2016–2017. *Weighted by sex and the size of the population in each capital.

HPV knowledge and vaccination by information source. POP-Brazil Study, 2016–2017. *Weighted by sex and the size of the population in each capital. In relation to HPV knowledge in women, being black, being of lower socioeconomic class and having a lower educational level were associated with having fewer correct answers. Among men, only primary and secondary education levels were risk factors for having fewer correct answers. The best information sources for HPV knowledge and vaccination were the combination of health professionals and the media (1.33%, 95% CI 1.03-1.70).

Discussion

This is the first nationwide study of young adults who use the public health system with the aim of evaluating knowledge about HPV and vaccination in Brazil. The factors associated with the percentage of correct answers about HPV differed by sex. Lower education level was the variable that most interfered with knowledge. Women scored higher than men, and the best information source was the combination of health professionals and the media. More than 70% of young adults had awareness about HPV vaccination, which is similar to figures in other countries (87% in United Sates [19] and 75% in Italy [20]). Previous regionally restricted and specific population data have shown HPV vaccination knowledge varying from 49.7% [21] to 77.93% [22]. However, having awareness of HPV did not ensure knowledge. Although most of the participants were aware of the HPV vaccine, they had little knowledge about the infection, especially about the link between sexual behavior and HPV-related cancers. Women reported having more knowledge about the HPV vaccine and the relationship between HPV and cervical cancer (56.56% in women vs. 43.43% in men) than men did, which is consistent with findings from other studies [21,[23], [24], [25]]. The number of correct answers is higher among women because the vaccination coverage that started in 2014 was only for female adolescents in Brazil. Vaccination coverage for males was not introduced into the public health system until 2017 [26]. Another possible factor is that women usually have more primary health care visits than men, as shown in the present study. However, this factor did not affect the number of correct answers. Several factors may be important for HPV vaccination status, i.e., demographic and socioeconomic factors, individual beliefs and knowledge, and behavioral aspects [27]. However, for HPV knowledge, these results showed that lower social class and education level were important associated factors [21]. Skin color/race was also a risk factor for fewer correct answers [19], but only in women. Therefore, the most vulnerable population was the most affected. Of the vaccination strategies adopted worldwide, vaccination was also made more available in primary care units and schools in Brazil [4]. Vaccination in schools is a proven strategy to increase vaccine coverage [8]. Brazil used this strategy in the first year of national vaccination and achieved very high coverage. In the subsequent year, the vaccinations were provided in primary care units, with a substantial decrease in coverage [1]. The school environment should be a place of discussion about sexual health and HPV, but such topics are considered taboo in Brazil [28]. The failure to include this theme in the curriculum may reflect the lack of influence of knowledge provided by schools in the study. In 2017, the cumulative vaccine coverage of HPV in girls aged 9–14 years was 82.6% for the first dose but only 52.8% for the second dose. For boys aged 12 to 13, the level of vaccine coverage with the first dose was even lower (43.8%) [1]. In addition to information provided in school, coverage can also be increased through dissemination by the media and health professionals, as the combination of these two was found to be the best information source for more correct answers about HPV. Although the majority of participants were aware of HPV because of the media, as previously reported [21], knowledge from this single source was not significant, showing that information dissemination campaigns are important but not sufficient. Since knowledge about HPV is still low, it is recommended that teachers, parents, and health professionals educate young adolescents about the transmission of HPV as well as associated diseases and methods of preventing infection. Despite being recognized as one of the most successful public health measures, vaccination is perceived as unsafe and unnecessary by a growing number of parents [29]. One of the arguments of the anti-vaccine movement that negatively impacted rates of coverage is the suspected side effects of the vaccine, but only 2.80% of participants reported being “afraid of its side effects” in this study. In addition, almost all women reported that they would undergo cytopathological exams even after receiving the vaccine. This observation may temper concerns that vaccination against HPV is likely to decrease cervical cancer screening behaviors [30]. The strength of this study is the nationwide sampling, with the inclusion of a large and diverse population. Furthermore, the data were collected face to face, in contrast to the data collection in most previous studies [31]. However, the study has some limitations. Several studies have already evaluated knowledge about HPV but used different forms of evaluation. There is no standardized method for the evaluation of knowledge. In this study, we used a scoring procedure because we believe that it is more appropriate than evaluating knowledge with only one question. Although the study participants were recruited from public health units, the study included participants of all social classes, with a distribution similar to that of the Brazilian population [18]. Finally, it is important to emphasize that a large portion of the studied participants were not the targets of the vaccination. In conclusion, the results reinforce the importance of educational interventions in the population, especially among the socially disadvantaged, to provide adequate information about the virus and vaccination. These findings can complement public health surveillance data on increasing the vaccination rate in the country.

Conflicts of interest

None.

Contributors

NLK and EMW contributed substantially to the conception and design of the work; NLK wrote the first draft; MB conducted the data analyses; all authors contributed to the interpretation of the data and approved the final version published, with EMW, GFH, JDCH, CMD, AGKM, FLAS, ASB, and GFP primarily responsible for revising the drafts for publication.
  21 in total

Review 1.  Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications.

Authors:  Eve Dubé; Maryline Vivion; Noni E MacDonald
Journal:  Expert Rev Vaccines       Date:  2014-11-06       Impact factor: 5.217

2.  Teenagers' knowledge about HPV infection and HPV vaccination in the first year of the public vaccination programme.

Authors:  F Sopracordevole; F Cigolot; V Gardonio; J Di Giuseppe; F Boselli; A Ciavattini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-02       Impact factor: 3.267

3.  [Knowledge and perception of HPV in the population over 18 years of age in the city of Ipatinga - State of Minas Gerais, Brazil].

Authors:  Mery Natali Silva Abreu; Angela Deise Soares; Diemack Alle Oliveira Ramos; Fernanda Vieira Soares; Gerson Nunes Filho; Analina Furtado Valadão; Patrícia Gonçalves da Motta
Journal:  Cien Saude Colet       Date:  2018-03

Review 4.  Factors impacting HPV vaccination: lessons for health care professionals.

Authors:  Annika M Hofstetter; Susan L Rosenthal
Journal:  Expert Rev Vaccines       Date:  2014-06-26       Impact factor: 5.217

5.  Human papillomavirus knowledge, beliefs, and behaviors: A questionnaire adaptation.

Authors:  Jaqueline D C Horvath; Natália L Kops; Juliana Caierão; Marina Bessel; Glaucia Hohenberger; Eliana M Wendland
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-09-13       Impact factor: 2.435

6.  Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations.

Authors: 
Journal:  Vaccine       Date:  2017-06-05       Impact factor: 3.641

7.  Observational studies: getting clear about transparency.

Authors: 
Journal:  PLoS Med       Date:  2014-08-26       Impact factor: 11.069

8.  Knowledge, Awareness and Attitude on HPV, HPV Vaccine and Cervical Cancer among the College Students in India.

Authors:  Shazia Rashid; Satyanarayana Labani; Bhudev C Das
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

9.  Catch-up HPV vaccination status of adolescents in relation to socioeconomic factors, individual beliefs and sexual behaviour.

Authors:  Maria Grandahl; Margareta Larsson; Tina Dalianis; Christina Stenhammar; Tanja Tydén; Ragnar Westerling; Tryggve Nevéus
Journal:  PLoS One       Date:  2017-11-03       Impact factor: 3.240

10.  Knowledge and Attitudes Regarding HPV and Vaccination Among Chinese Women Aged 20 to 35 Years in Fujian Province: A Cross-Sectional Study.

Authors:  Lihua Chen; Yiyi Song; Guanyu Ruan; Qiaoyu Zhang; Fen Lin; Jun Zhang; Ting Wu; Jian An; Binhua Dong; Pengming Sun
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

View more
  7 in total

1.  Quality evaluation of HPV vaccine-related online messages in China: a cross-sectional study.

Authors:  Wanzhou Wang; Jinliang Lyu; Mintao Li; Yunjing Zhang; Zhihu Xu; Yuanyuan Chen; Jiangjie Zhou; Shengfeng Wang
Journal:  Hum Vaccin Immunother       Date:  2020-10-15       Impact factor: 3.452

2.  Knowledge, Attitudes and Behaviors of Women who have or have not had human papillomavirus vaccine in Turkey about the Virus and the vaccine.

Authors:  Ezgi Agadayi; Dilay Karademir; Seher Karahan
Journal:  J Community Health       Date:  2022-04-27

3.  Knowledge, attitudes, and practices of adolescents regarding human papillomavirus.

Authors:  Mariana Portela Soares Pires Galvão; Telma Maria Evangelista de Araújo; Silvana Santiago da Rocha
Journal:  Rev Saude Publica       Date:  2022-04-01       Impact factor: 2.106

4.  Knowledge and Attitude Towards Human Papillomavirus Vaccine and Associated Factors Among Mothers Who Have Eligible Daughters in Debre Markos Town, Northwest Ethiopia.

Authors:  Melkam Tesfaye Sinshaw; Semarya Berhe; Siraye Genzeb Ayele
Journal:  Infect Drug Resist       Date:  2022-03-03       Impact factor: 4.003

5.  Sexual Behavior and the Awareness Level of Common Risk Factors for the Development of Cervical, Anogenital and Oropharyngeal Cancer among Women Subjected to HR HPV DNA-Testing.

Authors:  Agnieszka Wencel-Wawrzeńczyk; Piotr Lewitowicz; Angelika Lewandowska; Agnieszka Saługa
Journal:  Int J Environ Res Public Health       Date:  2022-08-04       Impact factor: 4.614

6.  Sex and educational attainment differences in HPV knowledge and vaccination awareness among unvaccinated-sexually active adults in Puerto Rico.

Authors:  Maira A Castañeda-Avila; Carla J Oramas Sepúlveda; Cynthia M Pérez; Jeslie M Ramos-Cartagena; Kimil Acosta Pagán; Josué Pérez-Santiago; Filipa Godoy-Vitorino; Ana P Ortiz
Journal:  Hum Vaccin Immunother       Date:  2022-06-13       Impact factor: 4.526

7.  --Human papillomavirus and Chinese international students in the United States: attitudes, knowledge, vaccination trends, healthcare behaviors, and sexual activity.

Authors:  Aaron Esagoff; Samuel A Cohen; Guoxuan Chang; Ozlem Equils; Sarah Van Orman
Journal:  Hum Vaccin Immunother       Date:  2021-03-11       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.